Phentermine is available in several strengths but 37.5 mg is the most commonly used dose. Although the drug can work well, it's only a short-term solution. The Food and Drug Administration (FDA) and ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a supplemental indication for phentermine/topiramate extended ...

October 3, 2012 (San Antonio, Texas) — Five studies of phentermine/topiramate were presented here at Obesity 2012: The Obesity Society 30th Annual Scientific ...

May 26, 2011 (New York, New York) — A pooled evaluation of three randomized weight-loss trials with an antiobesity medication--proposed name Qnexa (Vivus) for the ...

The oral dose for adults is 325 to 650 mg every 4 to 6 hours. The maximum daily dose is 4 grams. Child- the recommended dose is 10 to 15 mg/kg every 4 to 6 hours. Nausea, stomach pain, loss of ...

Qsymia (phentermine/topiramate) is a prescription drug approved for weight loss in adults and certain children. It comes as an extended-release oral capsule and is ...

Overweight people who took the phentermine/topiramate combination diet drug Qsymia lost more weight than people taking a placebo or either drug alone in a study ...

In a pilot study of 10 patients, adolescents who were placed on standard of care plus phentermine (Lomaira, Adipex-P) and topiramate (Trokendi XR, Qudexy XR, and Topamax) saw an average 4.3-point drop ...

The US FDA today approved a new weight loss drug that will be called Qsymia,the brand name for the combination of two previously approved drugs, phentermine and extended-release topiramate. The drug ...

Phentermine comes useful for the patients with a Body Max Index that either equals to or exceeds 30. Essentially, Phentermine is approved by a professional health care provider and not ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...